RE.DOCTOR Press Room

Post Types

RE.DOCTOR Enters Digital Therapeutics Market with Blood Glucose App

RE.DOCTOR Enters Digital Therapeutics Market with Blood Glucose App

??????? 28, 2024

RE.DOCTOR Enters Digital Therapeutics Market with Blood Glucose App. Digital Therapeutics company RE.DOCTOR announces first in line of chronic disease screening apps.

RE.DOCTOR introduces the Vital Signs Monitor

RE.DOCTOR introduces the Vital Signs Monitor

??????? 28, 2024

RE.DOCTOR introduces the Vital Signs Monitor: Collecting Physiologic Data for Health and Life Insurance Risk Assessment. By measuring indicators such as heart rate, blood pressure, respiratory rate and temperature, insurers gain valuable insights into policyholder health and wellness over time

RE.DOCTOR LLC Achieves ISO 13485 Certification

RE.DOCTOR LLC Achieves ISO 13485 Certification

??????? 28, 2024

RE.DOCTOR LLC Achieves ISO 13485 Certification, Underscoring Commitment to Quality and Patient Safety in Medical Device Development.

Improve Your Travel Assistance Performance: Collect Traveler Health Data to Decrease Fraud and Health Costs.

Improve Your Travel Assistance Performance: Collect Traveler Health Data to Decrease Fraud and Health Costs.

??????? 28, 2024

RE.DOCTOR, a leading provider of health data collection for travel assistance services, has announced a groundbreaking initiative aimed at improving travel assistance performance through the collection and analysis of traveler health data.

RE.DOCTOR Unveils Groundbreaking Web SDK for Vital Signs Scan, Revolutionizing Telehealth Solutions

RE.DOCTOR Unveils Groundbreaking Web SDK for Vital Signs Scan, Revolutionizing Telehealth Solutions

??????? 28, 2024

RE.DOCTOR Vital Signs Scan is an advanced platform that enables users to accurately measure essential health metrics such as heart rate, respiratory rate, and blood oxygen levels from the comfort of their homes.